| Literature DB >> 30982609 |
Long Guo1, Débora Romeo Bertola2, Asako Takanohashi3, Asuka Saito4, Yuko Segawa5, Takanori Yokota4, Satoru Ishibashi4, Yoichiro Nishida4, Guilherme Lopes Yamamoto6, José Francisco da Silva Franco7, Rachel Sayuri Honjo7, Chong Ae Kim7, Camila Manso Musso8, Margaret Timmons9, Amy Pizzino3, Ryan J Taft10, Bryan Lajoie10, Melanie A Knight11, Kenneth H Fischbeck11, Andrew B Singleton12, Carlos R Ferreira13, Zheng Wang14, Li Yan15, James Y Garbern16, Pelin O Simsek-Kiper17, Hirofumi Ohashi18, Pamela G Robey19, Alan Boyde20, Naomichi Matsumoto21, Noriko Miyake21, Jürgen Spranger22, Raphael Schiffmann23, Adeline Vanderver3, Gen Nishimura24, Maria Rita Dos Santos Passos-Bueno8, Cas Simons25, Kinya Ishikawa4, Shiro Ikegawa26.
Abstract
Colony stimulating factor 1 receptor (CSF1R) plays key roles in regulating development and function of the monocyte/macrophage lineage, including microglia and osteoclasts. Mono-allelic mutations of CSF1R are known to cause hereditary diffuse leukoencephalopathy with spheroids (HDLS), an adult-onset progressive neurodegenerative disorder. Here, we report seven affected individuals from three unrelated families who had bi-allelic CSF1R mutations. In addition to early-onset HDLS-like neurological disorders, they had brain malformations and skeletal dysplasia compatible to dysosteosclerosis (DOS) or Pyle disease. We identified five CSF1R mutations that were homozygous or compound heterozygous in these affected individuals. Two of them were deep intronic mutations resulting in abnormal inclusion of intron sequences in the mRNA. Compared with Csf1r-null mice, the skeletal and neural phenotypes of the affected individuals appeared milder and variable, suggesting that at least one of the mutations in each affected individual is hypomorphic. Our results characterized a unique human skeletal phenotype caused by CSF1R deficiency and implied that bi-allelic CSF1R mutations cause a spectrum of neurological and skeletal disorders, probably depending on the residual CSF1R function.Entities:
Keywords: CSF1R; HDLS; Pyle disease; dysosteosclerosis; leukoencephalopathy; mutation; osteoclast; osteosclerosis; skeletal dysplasia
Mesh:
Substances:
Year: 2019 PMID: 30982609 PMCID: PMC6507048 DOI: 10.1016/j.ajhg.2019.03.004
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025